HOOK
Hookipa Pharma Inc

3,028
Loading...
Loading...
News
all
press releases
Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm
Kaskela Law LLC announces that it is investigating HOOKIPA Pharma Inc. (NASDAQ: HOOK) on behalf of the companys shareholders. Since May 2024, shares of HOOKIPAs stock have declined from a trading...
Business Wire·1y ago
News Placeholder
More News
News Placeholder
Buy Rating and Price Target Increase for Hookipa Pharma Amid Clinical and Financial Progress
In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on Hookipa Pharma (HOOK Research Report), with a price targe...
TipRanks Financial Blog·1y ago
News Placeholder
Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views
Latest Ratings for HOOK DateFirmActionFromTo Feb 2022HC Wainwright & Co.MaintainsBuy Feb 2022SVB LeerinkMaintainsOutperform Nov 2021Morgan StanleyDowngradesOverweightEqual-Weight View More...
Benzinga·1y ago
News Placeholder
Buy Rating Affirmed for Hookipa Pharma on Emerging Oncology and Infectious Disease Pipelines
Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Hookipa Pharma (HOOK Research Report). The associated price target is...
TipRanks Financial Blog·1y ago
News Placeholder
HOOKIPA Pharma: Q4 Earnings Insights
read more...
Benzinga·1y ago
News Placeholder
Hookipa Pharma reports Q4 EPS (22c), consensus (19c)
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Best-in-class preliminary Phase 2 data for HB-200 in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancers in the first line setting Expect updated Phase...
Globe Newswire·1y ago
News Placeholder
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
NEW YORK and VIENNA, Austria, March 06, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, 'HOOKIPA'), a company developing a new class of immunotherapeutics based on its proprietary...
Globe Newswire·2y ago
News Placeholder
Hookipa Pharma to reduce workforce by 30%
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Hookipa Pharma announces focus on two strategic areas
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest HOOK News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.